NCT06951737Completed
Evaluation Of The Effect Of SGLT-2 Inhibitors On Atrial Fibrillation Recurrence In Diabetic Patients
Source: ClinicalTrials.gov · Last updated 3 Jun 2025
Brief summary (registry, in English)
Consecutive DCCV was performed until to achieve 120 patients in SR (60 DM patients who used SGLT-2 inhibitors and 60 DM patients who did not use SGLT-2 inhibitors). Patients defined as SGLT-2 inhibitor user group and control group. The two groups were monitored for AF recurrence on the first day, then at one, three, and six months after CV.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 120 (actual)
- First submitted
- 20 Apr 2025
- Start date
- 2 Oct 2022
- Primary completion date
- 2 Apr 2024
- Lead sponsor
- Bursa Postgraduate Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06951737
What you commit to
- Study type: Observational
- Participants enrolled: 120
- From 2 Oct 2022 to the primary completion date, 2 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients who have had coronary bypass surgery,
- patients with percutaneous or surgical bioprosthesis or metallic valve surgery.
Other illness
- malignancy patients,
- patients with acute or chronic inflammatory disease,
- patients with peripheral artery disease,
- patients with advanced valve stenosis or insufficiency,
Other
- patient who are not suitable for anticoagulant use,
- have thyroid dysfunction,
- glomerular filtration rate ≤ 25 ml/min/1.73 m²,
- patients whose sinus rhythm cannot be achieved with electrical cardioversion,
- patients with pacemakers,
Who the study is looking for
- patients \> 18 years and \< 90 years,
- Patient diagnosed with DM
- Patient underwent electrical cardioversion due to AF and was restored to sinus rhythm
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bursa Yüksek İhtisas Hastanesi Coordinator of this site? Confirm its status | Bursa | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.